This product utilizes the sandwich ELISA method with dual-specificity antibodies for the quantitative detection of residual DNase I in RNA process samples, aiding in the evaluation of mRNA drug quality during
drug development and CMC quality control stages. Biori's DNase I (P/N: BP-E04), which exhibits high enzymatic stability, significant enzymatic cleavage effects, and high protein purity. When used in conjunction with this assay kit, it achieves highly sensitive detection of DNase I content in RNA samples.
Product Features:
+86-756-8699969
Addr.: #333, Pingbei First Road, Nanping Industrial Park, Zhuhai, China 519000
Email:marketing@biori.com